News
Merck and Inbrain Neuroelectronics collaborate on graphene-based bioelectronic therapy technology [13-07-2021]
Major pharma company Merck has announced a collaboration agreement with Innervia Bioelectronics, a start-up and subsidiary of Inbrain Neuroelectronics S.L., Barcelona, Spain. The aim of the collaboration is to co-develop the next generation of graphene-based bioelectronic vagus nerve therapies targeting severe chronic diseases within the therapeutic areas addressed by Merck.
Related News
Quantum interference could lead to smaller, faster, and more energy-efficient transistors [25-03-2024]
Nanoelectronics, Graphene, Quantum Science
Researchers discover tightest arrangement of bilayer alkali metals between graphene layers [18-03-2024]
Graphene
Eurecat investigates manufacturing advanced materials with graphene for the automotive, aerospace, hydrogen energy and water treatment industries [09.03-2024]
Graphene
Umbrella for atoms: The first protective layer for 2D quantum materials [01-03-2024]
Graphene, Quantum Science, 2D Materials
Ultra-sensitive lead detector could significantly improve water quality monitoring [01-02-2024]
Graphene
CLOSE
Sitemap
  NEWS
  CONFERENCES
  JOBS
  PH REPORTS

© Phantoms Foundation 2024